|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3337824 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16754148.1 |
| Date of filing the European patent application | 2016-08-16 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/US2016/047146 |
| Date | 2016-08-16 |
| (87) | Number | WO 2017/031104 |
| Date | 2017-02-23 |
| (30) | Number | Date | Country code |
| 201562206246 P | 2015-08-17 | US |
| (72) |
PILLARISETTI, Kodandaram, US
BALDWIN, Eric Thomas, US
POWERS, Gordon D., US
CARDOSO, Rosa Maria Fernandes, US
ATTAR, Ricardo, US
GAUDET, Francois, US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Anti-BCMA antikūnai, bispecifinės antigeną surišančios molekulės, kurios suriša BCMA ir CD3, ir jų panaudojimas |
| ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 10 | 231.00 EUR |
| 2026-08-16 |